Tg Therapeutics Inc (TGTX)

EBITDA

$134.26M

TTM · Period ending: · USD

TGTX logo

TGTX EBITDA

Latest reported$134.26M
TGTX EBITDA (-$3.70M → $134.26M)
High-resolution chart · PNG

TGTX ebitda history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc EBITDA — Annual fiscal periods (USD)
Period endingEBITDA (USD)
134,361,000
49,902,000
26,100,000
-213,106,000
-341,969,000
-272,678,000
-167,302,000
-173,394,000
-118,393,660
-78,906,000
-63,164,564
-55,717,161
-19,524,199
-24,946,975
-881,974
1,898,093
-1,739,400
-3,927,958
-11,983,431
-9,633,270
-19,087,265
-5,868,689
-2,107,000
-995,461
-3,041,154
-3,086,397
-2,600,000
-3,000,000
-5,200,000
-3,700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.